NCT00054444 - Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2012

Conditions

Cervical AdenocarcinomaCervical Squamous Cell CarcinomaStage IB Cervical CancerStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage IVA Cervical Cancer

Interventions

DRUG

Topotecan Hydrochloride Liposomes

Given IV

RADIATION

3-Dimensional Conformal Radiation Therapy

DRUG

Cisplatin

Given IV

Trial Locations (10)

43210

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

43214

Riverside Methodist Hospital, Columbus

44109

MetroHealth Medical Center, Cleveland

52242

University of Iowa Hospitals and Clinics, Iowa City

60637

University of Chicago Comprehensive Cancer Center, Chicago

65212

University of Missouri - Ellis Fischel, Columbia

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74104

Cancer Care Associates-Midtown, Tulsa

74146

Tulsa Cancer Institute, Tulsa

08103

Cooper Hospital University Medical Center, Camden

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK